Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Colistimethate sodium

EU orphan designation number: EU/3/02/088
Active ingredient: Colistimethate sodium
Indication: Treatment of Pseudomonas aeruginosa lung infection (including colonisation) in cystic fibrosis
Sponsor: Forest Laboratories UK Ltd
Riverbridge House, Anchor Boulevard, Crossways Business Park, Dartford, Kent DA2 6SL, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/02/2002 Orphan designation EMEA/OD/057/01 (2002)648 of 19/02/2002
15/10/2009 Change of name and/or address of sponsor EMEA/OD/057/01
12/10/2011 Removal of orphan designation from Community Register